CLPT vs CUBE · rev $31.4M vs P/E 25, rev $1.07B
Clearpoint Neuro Inc (CLPT) versus CubeSmart (CUBE) — a side-by-side from cached financials, not a winner call.
Clearpoint Neuro Inc (CLPT) is a medical devices company listed on US.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Latest reported CLPT revenue for 2024-12-31 was $31.4M. Net income was -$18.9M. Revenue was up 31.0% from 2023-12-31 to 2024-12-31. CLPT currently screens at market cap $371.0M.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
CLPT currently screens at market cap $371.0M. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Not investment advice. Open the CLPT and CUBE stock pages for the full models.
Not investment advice.